Date | Price Target | Rating | Analyst |
---|---|---|---|
9/11/2024 | $45.00 | Buy | Citigroup |
6/28/2024 | $35.00 | Outperform | Macquarie |
National Post-Acute Platform Adds 53 Facilities, Five New States and Senior Living Vertical to Portfolio PACS Group, Inc. (NYSE:PACS) ("PACS") has finalized its acquisition of operations of 53 skilled nursing, assisted and independent living facilities from Prestige Care (Prestige), bringing its proven model to new geographical areas. The facilities span eight western states with 21 facilities in Oregon, 19 in Washington, six in Idaho, three in Nevada and one facility each in Alaska, Arizona, California and Montana. Collectively, the facilities comprise 2,511 skilled nursing beds and 1,334 assisted living and independent living units. "PACS is committed to growing as a legacy company. O
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced the closing of its upsized underwritten public offering of 19,034,482 shares of its common stock, which includes (i) 2,777,778 shares of its common stock sold by the Company and (ii) 16,256,704 shares of common stock sold by certain selling stockholders, which includes the exercise in full by the underwriters of their 30-day option to purchase an additional 2,482,758 shares of common stock from the selling stockholders, at a public offering price of $36.25 per share, for total gross proceeds of approximately $101 million to the Company and approximately $589 million to the selling stockholders, before deducting underwrit
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced the pricing of its upsized underwritten public offering of 16,551,724 shares of its common stock, which includes 2,777,778 shares of common stock sold by the Company and 13,773,946 shares of common stock sold by certain selling stockholders, at a public offering price of $36.25 per share, for total gross proceeds of approximately $101 million to the Company and approximately $499 million to the selling stockholders, before deducting underwriting discounts and commissions and offering expenses. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,482,758 sha
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced the commencement of an underwritten public offering of 13,888,890 shares of its common stock, including 2,777,778 shares of common stock sold by the Company and 11,111,112 shares of common stock sold by certain selling stockholders. The selling stockholders also expect to grant the underwriters a 30-day option to purchase up to an additional 2,083,332 of shares of common stock. PACS will not receive any proceeds from any sale of shares by the selling stockholders. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to th
Conference Call and Webcast scheduled for today, August 12, 2024, at 5:00 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the second quarter of 2024. Highlights: GAAP net income (loss) was $38.2 million for the six months ended June 30, 2024 and $(10.9) million for the second quarter of 2024, which was driven down by an increase in stock-based compensation expense of $90.9 million associated with restricted stock units, granted at the time of the Company's April 2024 initial public offering. Consolidated GAAP revenue for th
PACS Group, Inc. (NYSE:PACS) ("PACS Group" or the "Company"), today announced that it will release its second quarter 2024 financial results after market close on Monday, August 12, 2024. Management will host a call on Monday, August 12, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240806841957/en/PACS headquarters in Farmington, Utah. (Photo: Business Wire) PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://IR.pacs.com, or https://e
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") announced today that subsidiaries of the Company have agreed to acquire the operations of 53 skilled nursing and assisted/independent living facilities across 8 western states. The facilities are currently operated by Prestige, a family company whose legacy of caring for seniors dates back to the 1940s. The operations are located in 8 states, including Oregon (21 facilities), Washington (19 facilities), Idaho (6 facilities), Nevada (3 facilities), and one facility in each of Alaska, Arizona, California and Montana. Collectively, the facilities comprise 2,511 skilled nursing beds and 1,334 assisted living and independent living units.
Citigroup resumed coverage of PACS Group with a rating of Buy and set a new price target of $45.00
Macquarie initiated coverage of PACS Group with a rating of Outperform and set a new price target of $35.00
4 - PACS Group, Inc. (0002001184) (Issuer)
4 - PACS Group, Inc. (0002001184) (Issuer)
424B4 - PACS Group, Inc. (0002001184) (Filer)
EFFECT - PACS Group, Inc. (0002001184) (Filer)
S-1MEF - PACS Group, Inc. (0002001184) (Filer)
S-1 - PACS Group, Inc. (0002001184) (Filer)
8-K - PACS Group, Inc. (0002001184) (Filer)
10-Q - PACS Group, Inc. (0002001184) (Filer)
8-K - PACS Group, Inc. (0002001184) (Filer)
10-Q/A - PACS Group, Inc. (0002001184) (Filer)
PACS Group, Inc. (NYSE:PACS) ("PACS Group" or the "Company"), today announced that it will release its second quarter 2024 financial results after market close on Monday, August 12, 2024. Management will host a call on Monday, August 12, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240806841957/en/PACS headquarters in Farmington, Utah. (Photo: Business Wire) PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://IR.pacs.com, or https://e
Truist Securities analyst David Macdonald maintains PACS Group (NYSE:PACS) with a Buy and raises the price target from $32 to $36.
In the preceding three months, 11 analysts have released ratings for PACS Group (NYSE:PACS), presenting a wide array of perspectives from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 8 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 3 7 0 0 0 3M Ago 0 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $31.36, a high estimate of $35.00, and a low estimate of $27.00. Observing
Macquarie analyst Tao Qiu initiates coverage on PACS Group (NYSE:PACS) with a Outperform rating and announces Price Target of $35.
Gainers Anitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. Oragenics (AMEX:OGEN) shares increased by 4.24% to $2.04. The market value of their outstanding shares is at $9.1 million. PACS Group (NYSE:PACS) shares rose 3.95% to $31.52. The market value of their outstanding shares is at $4.8 billion. MultiPlan (NYSE:MPLN) shares moved upwards by 3.49% to $0.45. The market value of their outstanding shares is at $290.3 million. Nanoviricides (AMEX:NNVC) stock moved upwards by 2.01% to $2.48. The market value of their outstanding shares is at $29.2 million. Calidi Biotherapeutics (AME
The operations are located in 8 states, including Oregon (21 facilities), Washington (19 facilities), Idaho (6 facilities), Nevada (3 facilities), and one facility in each of Alaska, Arizona, California and Montana. Collectively, the facilities comprise 2,511 skilled nursing beds and 1,334 assisted living and independent living units. The Company will lease 37 of the facilities from a joint venture in which it owns a 25% interest. The remaining 16 facilities will be leased from unaffiliated third-party landlords.
Truist Securities analyst David Macdonald maintains PACS Group (NYSE:PACS) with a Buy and maintains $32 price target.
RBC Capital analyst Ben Hendrix maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $30 to $32.
Oppenheimer analyst Michael Wiederhorn maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $31 to $32.